Economic evaluation of vaccination against influenza in New Zealand

PharmacoEconomics

Volumn 9, Issue 1, 1996, Pages 51-60

  Scott, W Guy ^a,b   Scott, Helen M ^a,b  

^a Intl Ocean Inst Reg Ctr A   (New Zealand)

^b NONE   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AGED; ARTICLE; COST BENEFIT ANALYSIS; ECONOMIC ASPECT; GOVERNMENT; HEALTH EDUCATION; HEALTH INSURANCE; HIGH RISK POPULATION; HUMAN; INFLUENZA VACCINATION; NEW ZEALAND; PRIORITY JOURNAL; SOCIETY;

EID: 0030067702     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199609010-00006     Document Type: Article

References (24)

1. Wiselka M. Influenza: diagnosis, management, and prophylaxis. BMJ 1994; 308: 1341-5
2. Tobias M. Influenza vaccination still underutilised. N Ethicals 1991 Sep; 28 (9): 23-30
3. Jennings LC. Towards the control of influenza in New Zealand. Paper presented to the Public Health Commission and the Communicable Diseases Advisory Committee. Wellington: 1994 Dec 8
4. New Zealand Department of Health. Immunisation handbook. Wellington: Department of Health, 1993
5. Eisenberg JM, Schulman KA, Glick H, et al. Pharmacoeconomics: economic evaluation of pharmaceuticals. In: Strom BL, editor. Pharmacoepidemiology. 2nd ed. Chichester: Wiley, 1994: 469-93
6. International Classification of Diseases. 9th rev. ed. Clinical Modification (ICD-9CM). Ann Arbor (MI): WHO, 1978
7. Nichol KL, Margolis KL, Wuorenma J, et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778-84
8. Statistics New Zealand. INFOS (Information Network for Official Statistics: online computerised official statistics for New Zealand). Population statistics for 1992
9. Karalus NC, Cursons RT, Leng RA, et al. Community acquired pneumonia: aetiology and prognostic index evaluation Thorax 1991; 46: 413-8
10. Fedson DS, Wajda A, Nicol JP, et al. Clinical effectiveness of influenza vaccination in Manitoba. JAMA 1993; 270: 1956-61
11. New Zealand Ministry of Health. Hospital and selected morbidity data 1992. Wellington: Health Information Service, 1993
12. W Guy Scott and Associates Ltd. Survey of general practitioners adult consultation fees 1992. Wellington, 1992
13. McKendry CG, Muthumala D. Health expenditure trends in New Zealand: update to 1993 [appendix 5]. Wellington: Ministry of Health, 1994
14. Health Benefits Ltd, Health Benefits Centre. Cash and accrual report for regional health authority - combined: monthly reports for the year ended 1993. Wanganui (New Zealand): Health Benefits Centre, 1993
15. Core health and disability support services for 1993/94: first report of the National Advisory Committee on Core Health and Disability Support Services. Wellington: National Advisory Committee on Core Health and Disability Support Services, 1992
16. New Zealand Licenced Rest Homes Association Inc. An overview of the rest home industry. Wellington: New Zealand Licenced Rest Homes Association Inc., 1992
17. Riddiough MA, Sisk JE, Bell JC. Influenza vaccination: cost-effectiveness and public policy. JAMA 1983; 249: 3189-97
18. Schousboe M. The evaluation of influenza vaccination of Canterbury Health Laboratory staff: internal report. Christchurch: Canterbury Health Laboratories, 1993
19. Koopmanschap MA, Rutten FFH. Indirect costs in economic studies: confronting the confusion. PharmacoEconomics 1993; 4: 446-54
20. New Zealand Ministry of Health. Mortality and demographic data 1992. Wellington: Health Information Service, 1994
21. Nicholson KG. Influenza vaccination and the elderly. BMJ 1990; 310: 617-8
22. Sprenger MJW, Van Naelten MAMG, Mulder PGH, et al. Influenza mortality and excess deaths in the elderly, 1967-82. Epidemiol Infect 1989; 103: 633-41
23. US Department of Health and Human Services. Healthy people 2000: national health promotion and disease prevention objectives. Washington, DC: US Department of Health and Human Services, 1991
24. Nichol KL, Lind A, Margolis KL, et al. The effectiveness of vaccination against influenza in healthy working adults. N Engl J Med 1995; 333: 889-93